Latest Cyclin-dependent kinase Stories
M. D. Anderson researchers find better way to predict prognosis in patients treated with aromatase inhibitors; research also suggests a potential means of circumventing drug resistance.
Scientists at Dana-Farber Cancer Institute have uncovered the mechanism behind a promising new approach to cancer treatment: damaging cancer cells' DNA with potent drugs while simultaneously preventing the cells from repairing themselves.
NERVIANO, Italy, May 13 /PRNewswire/ -- The FDA has approved an Investigational New Drug (IND) application by Nerviano Medical Sciences to begin a phase I clinical study with its selective PLK-1 small molecule inhibitor for the treatment of cancer.
Researchers at the University of Pittsburgh School of Medicine, funded by JDRF, have discovered that adult beta cells have the ability to replicate with the help of a protein known as cdk6.
By Liu, Jingjing Zhang, Yiyue; Qin, Genji; Tsuge, Tomohiko; Sakaguchi, Norihiro; Luo, Guo; Sun, Kangtai; Shi, Dongqiao; Aki, Shiori; Zheng, Nuoyan; Aoyama, Takashi; Oka, Atsuhiro; Yang, Weicai; Umeda, Masaaki; Xie, Qi; Gu, Hongya; Qu, Li-Jia Following meiosis, plant gametophytes develop through two or three rounds of mitosis.
Sound Pharmaceuticals has received a R&D contract award from the Office of Naval Research for approximately $1.6 million to optimize its lead drug candidate for hearing regeneration.
Cyclacel Pharmaceuticals, Inc.